Astex Pharmaceuticals to Announce 2012 Fourth Quarter and Year-End Financial Results on February 25th

Astex Pharmaceuticals to Announce 2012 Fourth Quarter and Year-End Financial
Results on February 25th

DUBLIN, Calif., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc.
(Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and
development of novel small molecule therapeutics, today announced that it will
release its 2012 fourth quarter and fiscal year-end results on Monday,
February 25, 2013. James S.J. Manuso, PhD, chairman and chief executive
officer, and the Astex Pharmaceuticals management team will provide details of
the Company's financial results for fiscal year 2012.

A press release will be issued following the close of the market on February
25th.The Company will host a webcast conference call to discuss the results
at 4:30 p.m. ET.A live webcast of the call will be available in the Investor
Events section of the Company's website at www.astx.com.A webcast replay of
the conference call will be available shortly following the
event.Alternatively, you may access a replay of the conference call by
dialing (855) 859-2056 (domestic) and (404) 537-3406 (international); the
replay passcode number is 97672322.The webcast replay will be available for
30 days, and the telephone replay will be available for 7 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel
small molecule therapeutics with a focus on oncology.The Company is
developing a proprietary pipeline of novel therapies and is creating de-risked
products for partnership with leading pharmaceutical companies.Astex
Pharmaceuticals developed DACOGENĀ® (decitabine) for Injection and receives
significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit
http://www.astx.com.

The Astex Pharmaceuticals, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=12273

CONTACT: Timothy L. Enns
         Astex Pharmaceuticals, Inc.
         Senior Vice President
         Corporate Communications & Marketing
         Tel:  +1 (925) 560-2810
         E-mail:  tim.enns@astx.com
        
         Susanna Chau
         Astex Pharmaceuticals, Inc.
         Manager
         Investor Relations
         Tel:  +1 (925) 560-2845
         E-mail:  susanna.chau@astx.com
        
         Alan Roemer
         The Trout Group
         Managing Director
         Tel:  +1 (646) 378-2945
         E-mail: aroemer@troutgroup.com

Astex Pharmaceuticals, Inc. logo
 
Press spacebar to pause and continue. Press esc to stop.